VIVOS INC
Vivos Inc develops manufacturing equipments for the production of medical isotopes used in diagnosis and treatment of diseases.
VIVOS INC
Industry:
Biotechnology Health Care Manufacturing Medical Device
Founded:
2006-01-01
Address:
Kennewick, Washington, United States
Country:
United States
Website Url:
http://www.radiogel.com
Total Employee:
1+
Status:
Active
Contact:
509.736.4000
Email Addresses:
[email protected]
Total Funding:
875 K USD
Technology used in webpage:
Domain Not Resolving Euro Google Tag Manager Google Analytics Content Delivery Network LetsEncrypt HSTS Nginx Facebook Pixel Facebook Custom Audiences
Similar Organizations
Advanced Ultra-Violet Systems
Advanced Ultra-Violet Systems develops UV-C disinfection products for healthcare, education, hospitality, and business environments.
AdvantiGen Biosciences
AdvantiGen Biosciences develops protein-based tools for research and pharmaceutical industries, focusing on improving human health.
Sesen Bio, Inc.
Sesen Bio, Inc. is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.radiogel.com Semrush global rank: 8.5 M Semrush visits lastest month: 523
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 13.248.243.5
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Vivos Inc"
RadioGelâ„¢
RadioGel® is a division of Vivos Inc. and holds the patent for a next generation cancer treatment - Precision Radionuclide Therapy (PRnT)â„¢ The future of cancer treatment – the insertion of our radionuclide device directly into the tumor …See details»
Meet The Team - RadioGelâ„¢
Carlton M. Cadwell. Dr. Carlton Cadwell leverages over 30 years of experience in the corporate world leading Cadwell Laboratories, a major international provider of neurodiagnostic devices.See details»
Vivos Inc.
RadioGel®, not currently approved for human use, is our division dedicated to treating cancer in humans using our patented Precision Radionuclide Therapyâ„¢ (PRnTâ„¢). RadioGel® is a hydrogel liquid containing tiny yttrium-90 phosphate …See details»
RAdioGel®. - vivosinc.com
Our RadioGel® division assembled a team of talented and dedicated professionals who are passionate about improving cancer treatment through cutting edge technology and an …See details»
Vivos Inc. - RadioGelâ„¢
Currently RadioGel® is not approved for human therapy. Vivos Inc. (OTCQB: RDGL) Our patented Precision Radionuclide Therapyâ„¢ (PRnTâ„¢) is the future of cancer treatment – the …See details»
RadioGelâ„¢ - LinkedIn
RadioGelâ„¢ Biotechnology Research Richland, Washington 101 followers RadioGelâ„¢ is an yttrium-90 (90-Y) based Precision Radionuclide Therapy (PRnT) device to destroy cancer tumors in humans.See details»
Vivos Inc. Submits the Application to the FDA for Authority to …
Jun 28, 2024 RadioGel ® is a hydrogel liquid containing tiny yttrium-90 phosphate microparticles that may be administered directly into a tumor. The hydrogel is a yttrium-90 carrier at room …See details»
Radiogelâ„¢ Precision Radionuclide Therapy ... - Markets Insider
Dec 20, 2023 RadioGel â„¢ is a hydrogel liquid containing tiny yttrium-90 phosphate microparticles that may be administered directly into a tumor. The hydrogel is a yttrium-90 …See details»
Radiogel Precision Radionuclide Therapy Receives FDA ... - Nasdaq
Dec 20, 2023 RadioGel(TM) is a hydrogel liquid containing tiny yttrium-90 phosphate microparticles that may be administered directly into a tumor. The hydrogel is a yttrium-90 …See details»
Radiogel Precision Radionuclide Therapy Receives FDA …
Dec 20, 2023 RadioGel(TM) is a hydrogel liquid containing tiny yttrium-90 phosphate microparticles that may be administered directly into a tumor. The hydrogel is a yttrium-90 …See details»
Contact Us - RadioGelâ„¢
Vivos Inc. Suite N288 1030 N Center Parkway, Kennewick, Washington 99336, United States. [email protected]See details»
Radiogel™ Precision Radionuclide Therapy™ Receives FDA …
Richland WA, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to announce that the Food and Drug Administration has granted RadioGel Precision …See details»
IDE Submission - RadioGelâ„¢
The filing was an amendment, addressing the FDA comments to our previous application (Q211938/S001). Today’s IDE submission marks our first filing with the FDA following the …See details»
Radiogelâ„¢ Precision Radionuclide Therapyâ„¢ Receives FDA
Dec 20, 2023 --Vivos Inc., Vivos Inc is pleased to announce that the Food and Drug Administration has granted RadioGel Precision Radionuclide Therapy the designation as a …See details»
Radiogelâ„¢ Precision Radionuclide Therapyâ„¢ Receives FDA
Richland WA, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to announce that the Food and Drug Administration has granted RadioGel Precision …See details»
The Science of RadioGel®
Y-90 RadioGel® employs the high energy (2.3 MeV maximum), short-path length (11 mm maximum), pure beta-particle-emitting radionuclide yttrium-90 (physical half-life of 2.67 days), …See details»
Vivos Inc. Extended its IsoPet® Precision Radionuclide TherapyTM …
Sep 30, 2024 RadioGel ® also has a short half-life – delivering more than 90% of its therapeutic radiation within 10 days. This compares favorably to other available treatment options …See details»
Radiogelâ„¢ Precision Radionuclide Therapyâ„¢ Receives FDA
Dec 20, 2023 RadioGel â„¢ is a hydrogel liquid containing tiny yttrium-90 phosphate microparticles that may be administered directly into a tumor. The hydrogel is a yttrium-90 …See details»
RadioGel Precision Radionuclide Therapy Receives FDA ... - EQS …
Dec 20, 2023 RICHLAND, WA – (NewMediaWire) – December 20, 2023 — Vivos Inc. (OTCQB: RDGL), is pleased to announce that the Food and Drug Administration has granted RadioGel …See details»
Research Papers | RadioGelâ„¢
The yttrium-90-RadioGel® agent was designed to provide a safe, effective, localized, high-dose beta radiation for treating solid tumors. The properties of 90Y-RadioGel® also make it a …See details»